Here's Why Mallinckrodt Fell as Much as 14% Today
Investors continue to grapple with the uncertainty hanging over the company.
Mallinckrodt
MNK
MNK
$2.66
$0.11
4.3%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive MNK Charts
Mallinckrodt plc Ordinary Shares
News & Analysis: Mallinckrodt
The Fool has written over 100 articles on Mallinckrodt.
Why State Street, Mallinckrodt, and ArcelorMittal Jumped Today
Upbeat news on interest rates and asset sales lifted these stocks on an otherwise tough day for the market.
Here's Why Mallinckrodt Is Collapsing Today
The company is reportedly considering bankruptcy to cope with its financial exposure in the opioid crisis.
Why Mallinckrodt Stock Is Plunging Today
Worries about opioid litigation and a recent patent lawsuit loss continue to weigh on the drugmaker.
Why J.M. Smucker, Mallinckrodt, and Lancaster Colony Slumped Today
Find out how earnings affected some of these stocks.
Here's Why Mallinckrodt Fell Over 17% Today
The bad news keeps piling up.
Why Mallinckrodt and Endo International Shares Jumped Today
Investors appear to have some confidence that the companies will settle their opioid lawsuits.
Here's Why Mallinckrodt Dropped 12% Today
Positive clinical-trial results couldn't save the embroiled biotech.
Mallinckrodt (MNK) Q2 2019 Earnings Call Transcript
MNK earnings call for the period ending June 30, 2019.
Why Mallinckrodt Stock Is Dropping Today
The drugmaker's decision to suspend efforts to spin off its specialty generics business appears to be rattling investors.
